3.4.21.B42	diagnostics	elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a favorable prognosis in advanced high-grade serous ovarian cancer patients	752430	
3.4.21.B42	diagnostics	KLK11 splice variants represent potential cancer biomarkers	752890	
3.4.21.B42	diagnostics	the measurement of kallikrein-related peptidase 11, KLK11, might be a useful diagnostic and prognostic test for non-small cell lung cancer patients. Patients with a high enzyme activity have a longer longer overall survival and progression free survival	732964	
3.4.21.B42	medicine	K11 is a serum marker for the diagnosis of ovarian carcinoma	679272	
3.4.21.B42	medicine	KLK11 mRNA may serve as a marker to discriminate between benign prostatic hyperplasia and prostate cancer	667879	
3.4.21.B42	medicine	negative kallikrein 11 expression is associated with nearly 5fold increased risk of distant metastasis after curative gastrectomy in gastric cancer patients. Kallikrein 11 expression is a significant independent prognostic factor for disease-free survival and overall survival in gastric cancer patients	718041	
3.4.21.B42	medicine	overexpression of human kallikrein 11 is associated with poor prognosis in patients with low rectal carcinoma	693983	
3.4.21.B42	medicine	the down-regulation of KLK11 gene in advanced and more aggressive tumors opens the feasibility of being used as biomarker distinguishing the tumor aggressiveness and prognostic indicators for human prostate cancer	709810